Search
for
Sort by
Research 961–990 of 1000+
- 1361 A novel cell surface marker for hair follicle dermal cells throughout hair morphogenesis and cycling
- Tissue engineering of human hair follicles using a biomimetic developmental approach
- Factors affecting the development of alopecia areata in children
- Androgenetic Alopecia: Therapy Update
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Effect of Platelet-Rich Plasma (PRP) on Dermal Skin Flap Survival: An Experimental Study in Rats
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Macrophage-Centric Immunometabolic Crosstalk in Alopecia Areata Pathogenesis: Mechanisms and Therapeutic Implications
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Androgenetic Alopecia: An Update of Treatment Options
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Bioengineering of Hair Follicle-like Structure for Validation of Hair Growth Promoting Compounds
- Human Follicular Papilla Cells Carry Out Nonadipose Tissue Production of Leptin
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- THE EFFECT OF AUTOLOGOUS PLATELET RICH PLASMA (PRP) ON PATIENTS WITH ALOPECIA AREATA
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Baricitinib-loaded EVs promote alopecia areata mouse hair regrowth by reducing JAK-STAT-mediated inflammation and promoting hair follicle regeneration
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 570 Targeting JAK/STAT and Wnt/b-catenin pathways and 5a-reductase activity to develop an effective anti-hair loss product
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Treatment of Alopecia Areata with Simvastatin/Ezetimibe